This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

NYSE Moves On While Deutsche Boerse Stands Ground

Stocks in this article: NYX

P/>NEW YORK ( TheStreet) -- Even though NYSE Euronext (NYX) is moving on from its $7.4 billion scuttled merger with Deutsche Boerse, the European exchange will continue to contest an antitrust ruling blocking the deal that it called, "a black day for Europe and for its future competitiveness on global financial markets."

On Thursday NYSE Euronext said that it won't join its former partner in contesting the ruling. "While we continue to believe that the European Commission decision was based on an incorrect determination of the relevant market definition, we do not believe that the interests of our shareholders and our company would be served by undertaking a protracted appeal," NYSE Euronext said in a statement.

The proposed deal would have created the largest stock and derivatives exchange in Europe and one of the largest in the world, further tying NYSE Euronext's fate to the struggling region, while providing Deutsche Boerse entry to now rebounding U.S. markets.

While NYSE Euronext has moved on from the deal, Deutsche Boerse said earlier in March that it will contest a ruling by the European Commission that the merger would make some markets too concentrated.

The NYSE is moving ahead with plans to return $550 million to shareholders as it tries to continue growing earnings per share and operating profit margins. While NYSE investors reacted strongly to the deal breakup and capital return program in February, pushing shares over $30, Deutsche Boerse seems to be in far worse spirits on the deal breakup.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

European officials rejected the merger, calling it a "near-monopoly" in European exchange-traded derivatives.

The deal would have concentrated 90% of European exchange-traded derivatives markets and just under a third of equities trading under one operator. Both companies made attempts to quell competition concerns by opening the businesses to rivals and divesting some pieces; however in its rejection, European Commission called for the divestiture of either NYSE Euronext's Liffe platform or Deutsche Borse's Eurex business, two keys to the deal.

NYSE Euronext shareholders and analysts may cheer the decision to walk away, after the company announced a capital return program could grow to $1 billion. Meanwhile, the move may allow the company to consolidate its European exposure, instead of expanding it.

"Volume in NYX's four transaction businesses are all down year-over-year , and we believe the European businesses in particular could continue to experience headwinds," wrote KBW analyst Niamh Alexander of the company's fourth quarter earnings in February. Alexander rates shares a "market perform" with a $30 price target.

" We continue to view the standalone business as attractive at current levels... We also believe some investors prefer the standalone case as it keeps exposure to a challenging macro environment in Europe in check," wrote UBS analyst Alex Kramm in a February note. Overall, NYXE Euronext warrants a $31.73 a share price target, according to consensus estimates compiled by Bloomberg, with 10 "buy" and "hold" ratings, respectively and one "sell" rating.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs